wholesale sale hmg 75iu/vial*5

About Security Credit card payments

  Menotrophin for Injection
Product is to extract the urine of postmenopausal women refined glycoprotein gonadotropin, plus appropriate excipients by freeze-drying None
Bacteria products. Containing follicle stimulating hormone and luteinizing hormone two biologically active components, both the ratio of about 1.
Characters
This product is white or off-white freeze-dried lumps or powder. This product is dissolved in water.

Pharmacology and Toxicology
This product is a gonadotropin drugs. The main role of follicle stimulating hormone (FSH) to promote ovarian follicle development
Mature and testes generate and secrete steroidal sex hormones. To enable women to endometrial hyperplasia, male to promote the development of the seminiferous tubules, spermatogenic cell division and sperm maturation.

Pharmacokinetics
Intramuscular injection of this product can absorb, the peak plasma concentration time of 4 to 6 hours after administration of the peak of serum estradiol in 18 hours, increased 88% after the intravenous injection of 150IU drug Cmax was 24IU / L, Zhong Dafeng in 15 minutes, the elimination of two-phase, is mainly excreted by the kidneys, not been reported in breast milk secretion.

Indications
Combination with HCG, for lack of gonadotropin secretion due to primary or secondary amenorrhea, anovulation due to infertility.

Usage and dosage
Intramuscular injection, dissolved in 1 ~ 2ml sterile water for injection.
Start (or cycle of the fifth day) 1 75 150u, 1 time a day. Seven patients with estrogen levels and follicle development to adjust the dose increased to a daily 150 ~ 225u. Intramuscular injection of HCG follicular mature sex hormone (HCG) 10,000 u, ovulation induction. Injection three weeks after the ovary had no response, stop the medication.

Adverse reactions
Ovarian hyperstimulation syndrome, lower abdominal discomfort or swelling and flu, abdominal pain, nausea, vomiting, ovarian enlargement. Severe can cause chest tightness, shortness of breath, decreased urine output, pleural effusion, ascites, or follicular cyst rupture. In addition, there are more than pregnancy and premature.

Taboo
Allergies, premature ovarian failure, menopause, unexplained vaginal bleeding, uterine fibroids, ovarian cysts, ovarian enlargement disabled patients.

Note
A. Under the guidance of a doctor experienced gynecological endocrine medication. During the administration should periodically conduct a comprehensive inspection: B-type ultrasonic (monitoring of follicular development), cervical mucus examination and determination of estrogen levels and daily basal body temperature measurement.
Two. In case of severe ovarian hyperstimulation syndrome, should be discontinued immediately.
3. Asthma, heart disease, epilepsy, renal dysfunction, tumor or hypertrophy of the pituitary, thyroid or adrenal cortex function decline in patients with caution.

Pregnant women and lactating women drug
During pregnancy.

Drug Interactions
Is not clear.

Specification
75 units

Storage
Shading, sealed and kept in a dry place.
2 years